Literature DB >> 9266122

Do physicians discuss HIV testing during prenatal care?

G Ogilvie1, S Adsett, G Macdonald.   

Abstract

OBJECTIVE: To determine the frequency with which Hamilton, Ont, general practitioners and family physicians discussed and offered HIV testing during prenatal care.
DESIGN: Cross-sectional mailed survey.
SETTING: Family physicians' and general practitioners' offices in Hamilton, including group or solo private practices and community health centres. PARTICIPANTS: General practitioners and family physicians in Hamilton identified from the Ontario Medical Association and the 1995 Canadian Medical Directory. Two hundred forty-one practitioners were sent surveys; 25% had moved or no longer practised family medicine, and 65% (140 of 216) were returned. MAIN OUTCOME MEASURE: Frequency with which physicians discuss with and offer HIV testing to prenatal patients.
RESULTS: Eighty percent of clinicians felt they understood their professional role in providing HIV testing, and more than 90% had referred female patients for HIV testing. Eight percent of physicians always discussed HIV when reviewing pregnancy care, and 5% always offered HIV testing to patients in the first trimester of pregnancy.
CONCLUSIONS: Currently, few physicians discuss HIV testing with all their prenatal patients.

Entities:  

Mesh:

Year:  1997        PMID: 9266122      PMCID: PMC2255416     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

1.  The Ontario HIV seroprevalence study of childbearing women: results from the first year of testing.

Authors:  R A Coates; J W Frank; R Arshinoff; C Major; E Wallace; M E Millson; B McLaughlin; H Demshar; R Khazen; J Garbutt
Journal:  Clin Invest Med       Date:  1992-02       Impact factor: 0.825

2.  HIV testing practices of primary care physicians: an Ontario survey.

Authors:  E M Skotniski; C Woodward; B Hutchison; J Abelson; J Brown; G Norman
Journal:  Can J Public Health       Date:  1996 May-Jun

3.  Costs and benefits of screening pregnant women for HIV.

Authors:  H Bueckert
Journal:  CMAJ       Date:  1996-11-15       Impact factor: 8.262

4.  Is HIV testing in antenatal clinics worthwhile? Can we afford it?

Authors:  I L Chrystie; L Zander; A Tilzey; C D Wolfe; A Kenney; J E Banatvala
Journal:  AIDS Care       Date:  1995

5.  Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.

Authors:  R D Gorsky; P G Farnham; W L Straus; B Caldwell; D R Holtgrave; R J Simonds; M F Rogers; M E Guinan
Journal:  Public Health Rep       Date:  1996 Jul-Aug       Impact factor: 2.792

6.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

7.  Mandatory screening of pregnant women for the human immunodeficiency virus.

Authors:  C M Wilfert
Journal:  Clin Infect Dis       Date:  1994-10       Impact factor: 9.079

8.  Qualitative evaluation of the Canadian Medical Association's counselling guidelines for HIV serologic testing.

Authors:  M S Rowan; M Toombs; G Bally; D J Walters; J Henderson
Journal:  CMAJ       Date:  1996-03-01       Impact factor: 8.262

9.  Evidence for the effectiveness of CME. A review of 50 randomized controlled trials.

Authors:  D A Davis; M A Thomson; A D Oxman; R B Haynes
Journal:  JAMA       Date:  1992-09-02       Impact factor: 56.272

10.  Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications.

Authors:  K L MacDonald; J B Jackson; R J Bowman; H F Polesky; F S Rhame; H H Balfour; M T Osterholm
Journal:  Ann Intern Med       Date:  1989-04-15       Impact factor: 25.391

View more
  6 in total

1.  Maternity Care Guidelines checklist. To assist physicians in implementing CPGs.

Authors:  C M Kirkham; S Grzybowski
Journal:  Can Fam Physician       Date:  1999-03       Impact factor: 3.275

2.  Screening for HIV during pregnancy. Survey of physicians' practices.

Authors:  S E MacDonald; L A Hartling; R M Seguin; K S O'Connor; M L Rekart; D L Mowat; J R Hoey
Journal:  Can Fam Physician       Date:  2001-11       Impact factor: 3.275

3.  Prenatal HIV testing in Ontario: knowledge, attitudes and practices of prenatal care providers in a province with low testing rates.

Authors:  Dale Guenter; June Carroll; Janusz Kaczorowski; John Sellors
Journal:  Can J Public Health       Date:  2003 Mar-Apr

4.  Prenatal HIV tests. Routine testing or informed choice?

Authors:  Dale Guenter; Janusz Kaczorowski; June Carroll; John Sellors
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

5.  The potential anesthetic threats, challenges and intensive care considerations in patients with HIV infection.

Authors:  Sukhminder Jit Singh Bajwa; Ashish Kulshrestha
Journal:  J Pharm Bioallied Sci       Date:  2013-01

6.  High uptake of HIV testing in pregnant women in Ontario, Canada.

Authors:  Robert S Remis; Maraki Fikre Merid; Robert W H Palmer; Elaine Whittingham; Susan M King; Natasha S Danson; Lee Vernich; Carol Swantee; Carol Major
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.